Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Author(s)
Fessenden, Tim B; Stopfer, Lauren E; Chatterjee, Fiona; Zulueta, Julian; Mesfin, Josh; ... Show more
Thumbnail
DownloadPublished version (11.03Mb)
Publisher with Creative Commons License
Terms of use
Creative Commons Attribution NonCommercial License 4.0 https://creativecommons.org/licenses/by-nc/4.0/
Metadata
Show full item record
Date issued
2022
URI
https://hdl.handle.net/1721.1/146988
Department
Koch Institute for Integrative Cancer Research at MIT; Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Biology; Ragon Institute of MGH, MIT and Harvard
Journal
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Citation
Fessenden, Tim B, Stopfer, Lauren E, Chatterjee, Fiona, Zulueta, Julian, Mesfin, Josh et al. 2022. "Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins." Journal for ImmunoTherapy of Cancer, 10 (7).
Version: Final published version
Collections